Melqart Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Melqart Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-89,400	Closed	-$3.02M	–	119
2021 Q2	$3.02M	Buy	+89,400	New	+$2.28M	0.14%	66

Melqart Asset Management's CNST Position: Q3 2021 in Review

Melqart Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 89,400 shares — an estimated $3.02M sold.

Melqart Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $3.02M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Melqart Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Melqart Asset Management sold 89,400 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3.02M.
Melqart Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Melqart Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $3.02M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Melqart Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.